非编码RNA分子标志物对脓毒症的临床价值
脓毒症和脓毒性休克是重症患者的重要临床问题,是ICU首位死亡原因,因此早期诊断和治疗尤为重要。近期对脓毒症患者非编码RNA的全基因组表达分析显示,与健康个体相比,超过80%的非编码RNA存在差异表达。这些分子在固有免疫、线粒体功能和凋亡等生物学过程中发挥重要作用。miRNA、lncRNA和circRNA等非编码RNA日益被认为是多种信号通路的调节因子。通过研究可能作为脓毒症分子标志物的非编码RNA,探讨了调控性非编码RNA靶点治疗脓毒症的潜力,并评估了其临床价值。
要点
- 脓毒症患者非编码RNA全基因组表达分析显示,与健康个体相比超过80%存在差异表达。
- 非编码RNA在固有免疫、线粒体功能和凋亡等生物学过程中发挥重要作用。
- miRNA、lncRNA和circRNA等非编码RNA日益被认为是多种信号通路的调节因子。
- 调控性非编码RNA靶点具有治疗脓毒症的潜力,其作为分子标志物的临床价值受到评估。
适用人群与场景
- 脓毒症患者(ICU重症患者)
研究设计与关键结果
- 脓毒症患者非编码RNA全基因组表达分析显示,与健康个体相比超过80%存在差异表达。
- 非编码RNA在固有免疫、线粒体功能和凋亡等生物学过程中发挥重要作用。
- miRNA、lncRNA和circRNA等非编码RNA日益被认为是多种信号通路的调节因子。
- 通过研究可能作为脓毒症分子标志物的非编码RNA,探讨了调控性非编码RNA靶点治疗脓毒症的潜力,并评估了其临床价值。
证据类型、等级与局限
- 证据类型:综述
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis and septic shock are important clinical problems in critically ill patients, accounting for the first cause of death in intensive care unit (ICU). Therefore, early diagnosis and treatment are particularly important. Recently, genome-wide expression analysis of non-coding RNA in septic patients showed that more than 80% were differentially expressed compared with healthy individuals. These molecules play important roles in biological processes, including innate immunity, mitochondrial function and apoptosis. Therefore, a class of non-coding RNAs such as microRNA (miRNA), long-chain non-coding RNA (lncRNA) and circular non-coding RNA (circRNA) are increasingly recognized as a regulator of various signaling pathways. The potential of regulatory non-coding RNA target to treat sepsis was discussed by studying non-coding RNAs that might serve as molecular markers of sepsis, and its clinical value was evaluated.
参考来源
- Yuan J, Li M, Chang X, et al. [Clinical value of non-coding RNA molecular markers for sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31198158. doi:10.3760/cma.j.issn.2095-4352.2019.05.026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。